Edition:
United States

OBI Pharma Inc (4174.TWO)

4174.TWO on Gre Tai Securities Market of Chinese Taipei

180.00TWD
25 Sep 2017
Change (% chg)

NT$0.00 (+0.00%)
Prev Close
NT$180.00
Open
NT$185.00
Day's High
NT$185.00
Day's Low
NT$180.00
Volume
488
Avg. Vol
1,257,925
52-wk High
NT$403.00
52-wk Low
NT$173.00

Chart for

About

OBI Pharma, Inc. is a Taiwan-based company principally engaged in the development new pharmaceuticals. The Company mainly operates its business through research and development of novel cancer and infectious disease therapies. It also develops next generation active immunotherapy for difficult to treat cancers, including lung,... (more)

Overall

Beta: 0.05
Market Cap(Mil.): NT$30,980.82
Shares Outstanding(Mil.): 172.12
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 81.40 16.08
EPS (TTM): -- -- --
ROI: -- 3.18 14.60
ROE: -- 4.93 14.03

BRIEF-OBI Pharma buys TH-3424 from Threshold Pharmaceuticals

* OBI Pharma announces acquisition of TH-3424 from Threshold Pharmaceuticals

Jun 01 2017

Earnings vs. Estimates